Recruiting

Observational Study

Sponsor:

Boston University

Code:

NCT06088303

Conditions

Stress Disorders, Post-Traumatic

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Adjunctive writing to amplify response and engagement (AWARE)

Cognitive processing therapy (CPT)

Prolonged exposure (PE)

Study Details

Brief summary:

The purpose of this clinical trial is to learn whether existing treatments for posttraumatic stress disorder (PTSD) can be improved. Two treatments for PTSD, cognitive processing therapy (CPT) and prolonged exposure (PE) will be studied. CPT and PE are effective treatments that are widely available, but interventions are needed to improve patient outcomes in these treatments. The investigators have developed an Adjunctive Writing intervention for Amplifying Response and Engagement (AWARE), which was designed using health communication strategies to enhance CPT and PE by improving communication between patients and therapists about patients' experiences in treatment. This research will investigate whether adding AWARE to CPT and PE will lead to better treatment outcomes compared to CPT and PE provided as usual without AWARE. AWARE includes a brief writing task asking patients about their experiences in treatment, as well as guided therapist responses to improve patient-therapist communication about patients' experiences in treatment. In the first phase of the study (case series phase), CPT or PE with AWARE will be provided to four adults with PTSD to pilot test adding AWARE to CPT and PE, seek patient and provider feedback, and refine AWARE. The first four participants who enroll will be part of the case series and will receive CPT or PE with AWARE. Then, in the second phase of the study, the randomized controlled trial (RCT) phase, the investigators will enroll 50 more adults with PTSD who will be randomly assigned (like flipping a coin) to receive CPT/PE as usual or CPT/PE with AWARE. It is expected that 25 participants will be randomized to CPT/PE with AWARE and 25 participants will be randomized to receive CPT/PE provided as usual. The goals of the RCT phase are to study whether AWARE is acceptable to patients, whether it is feasible to add AWARE to CPT and PE, and whether adding AWARE to CPT and PE improves patient-therapist communication and treatment outcomes compared to CPT/PE as usual.

Conditions

Stress Disorders, Post-Traumatic

Study ID

NCT06088303

Start date

Jan 15, 2025

Status verified date

Mar, 2026

Completion date

Dec, 2028

Anticipated

Primary completion date

Oct, 2028

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Inclusion Criteria:

  • Diagnosis of PTSD
  • Stable on psychiatric medications for at least 4 weeks

Exclusion Criteria:

  • Current unstable bipolar disorder
  • Current psychosis
  • Current active suicidal or homicidal ideation with intent or plan
  • Current severe substance use that warrants immediate medical attention
  • Current trauma-focused treatment
  • Significant cognitive impairment that would prevent engagement in assessments and therapy (e.g., advanced dementia, severe traumatic brain injury).

Study Design

Enrollment

54 participants

Anticipated

Allocation

Randomized

Intervention Model

Parallel Assignment

Primary purpose

Treatment

Interventions and Outcome Measures

Arms

experimental: CPT/PE with AWARE

Participants randomized into this arm will receive either cognitive processing therapy (CPT) or prolonged exposure (PE) with the adjunctive writing intervention to amplify response and engagement (AWARE).

CPT and PE are both recommended as gold standard treatments by published PTSD clinical practice guidelines. Participants will choose whether to receive CPT or PE. The standard treatment length will be 8-15 weekly sessions; however, participants and providers may collaboratively agree to early completion or additional sessions as warranted. AWARE will be integrated into the CPT/PE sessions.

active comparator: CPT/PE TAU

Participants randomized into this arm will receive either cognitive processing therapy (CPT) or prolonged exposure (PE) treatment as usual (TAU).

CPT and PE are both recommended as gold standard treatments by published PTSD clinical practice guidelines. Participants will choose whether to receive CPT or PE. The standard treatment length will be 8-15 weekly sessions; however, participants and providers may collaboratively agree to early completion or additional sessions as warranted.

Interventions

Adjunctive writing to amplify response and engagement (AWARE)

AWARE includes two components: 1) patients complete brief writing prompts asking about their experiences in treatment, and 2) therapists review patients' responses and facilitate guided discussion related to patients' experiences during check-ins at the beginning of each session.

Cognitive processing therapy (CPT)

CPT is a manualized, evidence-based therapy for PTSD typically delivered over the course of 8-15 weekly 60-minute sessions. CPT focuses on helping patients identify trauma-related stuck points (inaccurate and/or unhelpful beliefs) and challenge those beliefs to arrive at healthier, more balanced beliefs about their traumatic experiences, themselves, others, and the world.

Prolonged exposure (PE)

PE is a manualized, evidence-based therapy for PTSD typically delivered over the course of 8-15 weekly 90-minute sessions. PE focuses on reducing unhelpful avoidance and helping patients process and make sense of their traumatic experiences through in vivo and imaginal exposure to trauma-related reminders and memories.

Primary outcome measure

  • Patient-provider communication: VR-CoDES (Posttreatment) [ Time Frame: Immediately after ending treatment ]
  • PTSD: CAPS-5 (Posttreatment) [ Time Frame: Immediately after ending treatment ]
  • PTSD: CAPS-5 (Follow-up) [ Time Frame: 3 months after ending treatment ]
  • Feasibility assessed by CPT adherence [ Time Frame: Immediately after ending treatment ]
  • Feasibility assessed by CPT competence [ Time Frame: Immediately after ending treatment ]
  • Feasibility assessed by PE adherence [ Time Frame: Immediately after ending treatment ]
  • Feasibility assessed by PE competence [ Time Frame: Immediately after ending treatment ]
  • Acceptability: Client satisfaction (Mid-treatment) [ Time Frame: After 6 sessions ]
  • Acceptability: Client satisfaction (Posttreatment) [ Time Frame: Immediately after ending treatment ]
  • Acceptability: Therapeutic Alliance (Mid-treatment) [ Time Frame: After 6 sessions ]
  • Acceptability: Therapeutic Alliance (Posttreatment) [ Time Frame: Immediately after ending treatment ]
  • Treatment Completion [ Time Frame: Immediately after ending treatment ]

Central Contacts and Locations

Central contacts

Locations

National Center for PTSD at VA Boston Healthcare System

Recruiting

Boston, Massachusetts, United States, 02130

Contacts

Elizabeth Alpert, PhD

elizabeth.alpert@va.gov

More Information

Sponsor

Boston University

Last update posted

Apr 1, 2026

Last verified

Mar, 2026

Keywords

  • Posttraumatic stress disorder
  • Cognitive processing therapy
  • Prolonged exposure
  • Adjunctive writing for amplifying response and engagement
  • Health communication
  • Patient-provider communication

Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by Boston University on 2026-04-01.